1 |
Bianchi B.R., Lynch K.J., Touma E, Niforatos W, Burgard E.C., Alexander K.M., Park H.S., Yu H, Metzger R, Kowaluk E, Jarvis M.F., van Biesen T.: Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol. 376:127-38, 1999
DOI
ScienceOn
|
2 |
Bo X, Zhang Y, Nassar M, Burnstock G, Schoepfer R.: A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett. 375:129-33, 1995
DOI
ScienceOn
|
3 |
Ikeda M, Characterization of functional P2X(1) receptors in mouse megakaryocytes. Thromb Res. 119:343-53, 2007
DOI
ScienceOn
|
4 |
North R.A.: Molecular physiology of P2X receptors. Physiol Rev. 82:1013-67, 2002
DOI
|
5 |
North R.A., Surprenant A.: Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol. 40:563-80, 2000
DOI
ScienceOn
|
6 |
Toulme E, Soto F, Garret M, Boue-Grabot E.: Functional properties of internalization-deficient P2X4 receptors reveal a novel mechanism of ligand-gated channel facilitation by ivermectin. Mol Pharmacol. 69:576-87, 2006
DOI
ScienceOn
|
7 |
Ralevic V, Burnstock G.: Receptors for purines and pyrimidines. Pharmacol Rev. 50:413-92, 1998
|
8 |
Dutton JL, Poronnik P, Li GH, Holding CA, Worthington RA, Vandenberg RJ, Cook DI, Barden JA, Bennett MR.: P2X(1) receptor membrane redistribution and down-regulation visualized by using receptor-coupled green fluorescent protein chimeras. Neuropharmacology. 23;39:2054-66, 2000
|
9 |
Woodward JJ, Nowak M, Davies DL.: Effects of the abused solvent toluene on recombinant P2X receptors expressed in HEK293 cells. Mol Brain Res. 125:86-95, 2004
DOI
ScienceOn
|
10 |
Jones C.A., Chessell I.P., Simon J, Barnard E.A., Miller K.J., Michel A.D., and Humphrey P.P.: Functional characterization of the P2X4 receptor orthologues. Br J Pharmacol. 129: 388-394, 2000
DOI
ScienceOn
|
11 |
Burnstock G.: Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther. 110:433-54, 2006
DOI
ScienceOn
|
12 |
Boeynaems J.M., Communi D, Gonzalez N.S., Robaye B.: Overview of the P2 receptors. Semin Thromb Hemost. 31:139-49, 2005
DOI
ScienceOn
|
13 |
Evans R.J., Lewis C, Buell G, Valera S, North R.A., Surprenant A.: Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol Pharmacol. 48:178-83, 1995
|
14 |
Khakh B.S., North R.A.: P2X receptors as cell-surface ATP sensors in health and disease. Nature. 442:527-32, 2006
DOI
ScienceOn
|
15 |
Priel A, Silberberg S.D.: Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Physiol. 123: 281-293, 2004
DOI
ScienceOn
|
16 |
Burgard E.C., Niforatos W, van Biesen T, Lynch K.J., Touma E, Metzger R.E., Kowaluk E.A., Jarvis M.F.: P2X receptormediated ionic currents in dorsal root ganglion neurons. J Neurophysiol. 82:1590-8, 1999
DOI
|
17 |
Townsend-Nicholson A, King B.F., Wildmann S.S., and Burnstock G. Molecular cloning, functional characterization and possible cooperativity between murine P2X4 and P2X4a receptors. Mol Brain Res. 64: 246-254, 1999
DOI
ScienceOn
|
18 |
Hamilton SG.: ATP and pain. Pain Pract. 2:289-94, 2002
DOI
ScienceOn
|
19 |
Sim J.A., Park C.K., Oh S.B., Evans R.J., North R.A.: P2X(1) and P2X(4) receptor currents in mouse macrophages. Br J Pharmacol. 152:1283-90, 2007
DOI
ScienceOn
|
20 |
Burnstock G.: Purine and pyrimidine receptors. Cell Mol Life Sci. 64:1471-83, 2007b
DOI
|
21 |
Burnstock G.: Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev. 87:659-797, 2007a
DOI
ScienceOn
|